Lv42
430 积分 2022-01-23 加入
Elsevier FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia
2小时前
待确认
Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b+CD64+ patients with acute myeloid leukemia
2小时前
已完结
FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia
2小时前
已完结
成人急性髓系白血病（非急性早幼粒细胞白血病）中国诊疗指南（2023年版）
8个月前
已完结
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia
1年前
已完结
Drug resistance factors in acute myeloid leukemia: a comparative analysis
1年前
已完结
Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML
1年前
已完结
皖公网安备34019202002308
